|

PSMA-UCAR T (BRL-302) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Changzheng Hospital1

Indications

  • Castration-resistant Prostate Cancer1
  • Metastatic Castration-resistant Prostate Cancer1
  • Metastatic Prostate Cancer1
  • Cancer1

Other1 trial

Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.